A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2004
11/17/2004	EP1476551A2 Method for the identification of tissue-specific regulatory sequences
11/17/2004	EP1476542A1 Agent for inducing or inhibiting an angiogenesis
11/17/2004	EP1476492A1 Carbohydrate-modified polymers, compositions and uses related thereto
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476457A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SiNA)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476199A2 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
11/17/2004	EP1476187A2 Methods of extending corneal graft survival
11/17/2004	EP1476186A1 Use of an inhibitor or antagonist against tissue factor
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1363658B1 Beta-endorphin / crf - gene therapy for combatting pain locally
11/17/2004	EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1180168B1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
11/17/2004	EP1176968B1 Selenium-containing pro-drugs for cancer therapy
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1073427B1 Periadventitial delivery device
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0928190B1 Nucleic acid particle delivery
11/17/2004	EP0652972B1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure
11/17/2004	CN1547617A Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
11/17/2004	CN1547478A Use of fucans in the treatment of adhesions, arthritis and psoriasis
11/17/2004	CN1546669A DNA vaccine carrier of non-resistance choosing and its construction method
11/17/2004	CN1546664A Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses
11/17/2004	CN1176098C Triplex forming oligonucleotides and their use in anti-HBV
11/17/2004	CN1176010C Modified nano silicon particles
11/17/2004	CA2470177A1 System and method for controlling user interface properties with data
11/16/2004	US6818757 Nucleotide sequences coding preferential regulatory elements; for use in controlling heart gene expression; for use in induction of embryonic and bone marrow cells; for detection of heart associated differentiation
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818627 Nuclear localization sequence fragment of hiv-1 vpr protein conjugated to nucleotide; drug delivery, antiproliferative agents
11/16/2004	US6818626 Chelating systems for use in the delivery of compounds to cells
11/16/2004	US6818617 EC-3, an inhibitor of α4β1 and α4β7 integrins
11/16/2004	US6818448 Isolated cell comprising HAPP 670/671 DNAS sequences
11/16/2004	US6818447 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818444 Nucleotide sequences coding preferential polypeptide for use in treatment of immune defects in animals; for use in veterinary medicine
11/16/2004	US6818439 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
11/16/2004	US6818428 For diagnosing spondyloepimetaphyseal dysplasia (semd)/detection of alleles in humans; gene/protein therapy; fusion proteins; hiv tat genes/proteins
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	US6818210 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/16/2004	US6818209 Capable of transducing target cells; includes nucleotide sequence encoding at least part of rabies g protein material
11/16/2004	US6818016 Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
11/11/2004	WO2004097039A2 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
11/11/2004	WO2004097025A2 A method of transducing neural stem cells bound to a fibronectin fragment
11/11/2004	WO2004097016A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby
11/11/2004	WO2004096996A2 Modulation of glucagon receptor expression
11/11/2004	WO2004096257A2 Genetic modification of targeted regions of the cardiac conduction system
11/11/2004	WO2004096140A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/11/2004	WO2004096126A2 Treating hepatocellular carcinomas using therapeutic viruses
11/11/2004	WO2004096117A2 Drug delivery systems comprising transferrin-nucleic acid conjugates
11/11/2004	WO2004096016A2 Modulation of glucagon receptor expression
11/11/2004	WO2004078713A3 Morpholino based activity mapping
11/11/2004	WO2004064773A3 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
11/11/2004	WO2004064750A3 Improved constructs for expressing lysosomal polypeptides
11/11/2004	WO2004058801A3 Modified vaccinia ankara expressing p53 in cancer immunotherapy
11/11/2004	WO2004048583A3 Compositions and systems for the regulation of genes
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	WO2004024872A3 Method for expression of small antiviral rna molecules within a cell
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides
11/11/2004	WO2003079982A3 Gene amplification in cancer
11/11/2004	WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004	WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040224912 For therapy and prophylaxis of hyperproliferative disorder
11/11/2004	US20040224909 For inhibiting proliferation of a human tumor cell
11/11/2004	US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening
11/11/2004	US20040224891 Methods for the early diagnosis of ovarian cancer
11/11/2004	US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004	US20040224879 Devices and processes for distribution of genetic material to mammalian limb
11/11/2004	US20040224409 Replication defective plasmid comprising nucleotide sequences coding nerve growth factor for use in the treatment and/or prevention of degenerative neurological diseases; tissue engineering and targeted therapy
11/11/2004	US20040224405 Using RNA interference to control gene expression in cells; antisense agents and genetic suppressor elements; tissue targeted therapy and engineering
11/11/2004	US20040224404 Conditionally replicating viral vectors and their use
11/11/2004	US20040224403 Reconstituting hematopoietic cell function using human embryonic stem cells
11/11/2004	US20040224389 Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
11/11/2004	US20040224387 Comprises nucleotide sequences coding fibroblast growth factors for use in prevention and treatment of reproductive, metabolic, kidney, oral, breast, skin and brain disorders; wound healing agents and cosmetic surgery
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004	US20040224316 Using phosphodiesterase 4 inhibitor to treat cognitive training disorders; learning enhancement and enzyme inhibitors
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004	US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery
11/11/2004	US20040224026 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040224022 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040223979 Chimeric flavivirus vaccines
11/11/2004	US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223960 lipid hydrolyzing protein or polypeptide, particularly the protein lysosomal acid lipase; treating atherosclerosis, Wolman's Disease and Cholesteryl Ester Storage Disease
11/11/2004	US20040223953 Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects
11/11/2004	US20040223952 Generation and/or reduction of new lung tissue in an affected lung
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523600A1 Methods utilising g-protein coupled receptor 54
11/11/2004	CA2523579A1 Biological pacemaker
11/11/2004	CA2523575A1 Genetic modification of targeted regions of the cardiac conduction system
11/11/2004	CA2523517A1 Bcl2l12 polypeptide activators and inhibitors

1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 870